Clinically Explainable Prediction of Immunotherapy Response Integrating Radiomics and Clinico-Pathological Information in Non-Small Cell Lung Cancer †.
Simple Summary: Only 20% patients with non-small cell lung cancer respond to immunotherapy alone and 40% to immunotherapy in combination with chemotherapy. The PD-L1 value cutoff from immunohistochemistry that is used to select patients who would respond to immunotherapy lacks accuracy. A combinatio...
| Publicado en: | Cancers Vol. 17; no. 16; pp. 2679 - 2700 |
|---|---|
| Autores principales: | , , |
| Formato: | diagnostic images pictorial research tables/charts Journal Article |
| Publicado: |
MDPI
Aug2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |